Kimberly-Clark(US:KMB) ZACKS·2024-10-17 14:21Core Viewpoint - Analysts expect Kimberly-Clark (KMB) to report quarterly earnings of $1.69 per share, reflecting a year-over-year decline of 2.9%, with revenues projected at $5.06 billion, down 1.3% from the previous year [1] Earnings Estimates - Changes in earnings estimates are crucial for predicting investor reactions, with empirical studies showing a strong relationship between earnings estimate revisions and short-term stock performance [2] Key Metrics Forecast - Analysts estimate 'Net Sales- Personal Care' at $2.72 billion, indicating a year-over-year increase of 0.8% [4] - 'Net Sales- K-C Professional' is projected to reach $791.88 million, reflecting a decline of 7.3% year-over-year [4] - 'Net Sales- Corporate & Other' is expected to be $11.01 million, suggesting a slight increase of 0.1% from the previous year [4] Revenue Breakdown - 'Net Sales- Consumer Tissue' is forecasted at $1.55 billion, down 1.2% from the prior year [5] - 'Geographic Revenue- Outside North America' is expected to be $2.29 billion, indicating a decrease of 2.3% year-over-year [5] - 'Geographic Revenue- North America' is projected to reach $2.82 billion, reflecting a decline of 1% from the previous year [5] Organic Sales Growth - 'K-C Professional - Organic Sales Growth - YoY change' is estimated at 1.6%, down from 4% in the previous year [6] - 'Personal Care - Net price impact - YoY change' is expected to be 3.0%, compared to 4% reported last year [6] - 'Consumer Tissue - Net price impact - YoY change' is projected at 0.1%, down from 5% in the same quarter last year [7] Overall Performance - Total Organic Sales Growth is expected to be 3.5%, down from 5% in the previous year [8] - 'Personal Care - Organic Sales Growth - YoY change' is forecasted at 5.7%, compared to 7% reported last year [8] - Over the past month, Kimberly-Clark shares have returned +3.4%, slightly underperforming the Zacks S&P 500 composite's +3.8% [8]